HEATHER BECERRIL: Open Payments
NPI 1306429311 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 30 payments from 11 companies in 2025. Trend: 2023 $270 · 2024 $828 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $337 |
| Novo Nordisk Inc | 10 | $198 |
| Lilly USA, LLC | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: Korlym, Wegovy, Ozempic, MOUNJARO, Kerendia, NP Thyroid 60, Bimzelx, ACCRUFER.
Industry payments across UT — which companies pay providers there.
